Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
26
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
53%
ALSO IN BBP
BBP
70
HOLDINGS
42%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 3.2% | 1.5% | 1.5% |
|
REGENERON PHARMACEUTICALS | 2.8% | 1.4% | 1.4% |
|
GILEAD SCIENCES INC | 2.9% | 1.4% | 1.4% |
|
UNITED THERAPEUTICS CORP | 2.6% | 1.4% | 1.4% |
|
BIOGEN IDEC INC | 3.5% | 1.4% | 1.4% |
FTXH Overweight Relative to BBP
|
ELI LILLY & CO | 7.6% |
|
ABBVIE INC | 7.5% |
|
JOHNSON & JOHNSON | 7.1% |
|
MERCK & CO. INC. | 7.1% |
|
BRISTOL-MYERS SQUIBB CO | 6.7% |
|
VIATRIS, INC. | 3.9% |
|
CARDINAL HEALTH INC | 3.4% |
|
PFIZER INC | 3.0% |
 |
JAZZ PHARMACEUTICALS PLC | 2.6% |
|
ILLUMINA INC | 2.2% |
FTXH Underweight Relative to BBP
|
OMEROS CORP | -1.7% |
|
AGIOS PHARMACEUTICALS INC | -1.7% |
|
SAREPTA THERAPEUTICS INC | -1.6% |
|
NUVATION BIO INC CLASS A | -1.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | -1.6% |
|
CYTOKINETICS INC | -1.6% |
|
KURA ONCOLOGY, INC. | -1.6% |
|
GERON CORP | -1.6% |
|
RHYTHM PHARMACEUTICALS, INC. | -1.6% |
|
CRISPR THERAPEUTICS AG | -1.6% |